Related Experiment Video
Updated: May 2, 2026

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Establishing a high-risk neuroblastoma cohort using the Pediatric Health Information System Database
Ami V Desai1,2,3, Marko Kavcic1, Yuan-Shung Huang4
1Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Insights
Identifying high-risk neuroblastoma patients in administrative data is challenging due to missing International Classification of Diseases, 9th Revision (ICD-9) codes. A validated algorithm using ICD-9 codes, exclusion criteria, and chemotherapy data successfully identified a high-risk neuroblastoma cohort.
Area of Science:
- Pediatric Oncology
- Health Informatics
- Clinical Epidemiology
Background:
- The absence of specific International Classification of Diseases, 9th Revision (ICD-9) codes for neuroblastoma hinders patient identification in administrative databases.
- Accurate patient identification is crucial for epidemiological studies and comparative effectiveness research in pediatric cancers.
Purpose of the Study:
- To develop and validate a reliable algorithm for identifying a high-risk neuroblastoma cohort within the Pediatric Health Information System (PHIS) database.
- To create a valuable data resource for future research on high-risk neuroblastoma.
Main Methods:
- A three-step algorithm was designed, incorporating ICD-9 codes, specific exclusion criteria, and manual review of chemotherapy billing data.
- The algorithm was applied to the PHIS database to assemble a cohort of high-risk neuroblastoma patients (n = 952).
- Validation was performed at a single institution, assessing sensitivity and positive predictive value (PPV).
Main Results:
- The developed algorithm demonstrated high performance, achieving a sensitivity of 89.1% and a positive predictive value (PPV) of 96.1%.
- A cohort of 952 high-risk neuroblastoma patients was successfully identified and assembled.
- The methodology provides a robust approach for identifying similar patient cohorts in administrative datasets.
Conclusions:
- The algorithm effectively overcomes the limitation of missing ICD-9 codes for neuroblastoma identification.
- The identified high-risk neuroblastoma cohort serves as a valuable resource for future clinical epidemiology and comparative effectiveness studies.
- This approach enhances the utility of administrative databases for research in rare pediatric cancers.
Abstract:
International Classification of Diseases, 9th Revision (ICD-9) code(s) for neuroblastoma do not exist, preventing identification of these patients in administrative databases. To overcome this challenge, a three-step algorithm, using ICD-9 codes, exclusion criteria, and manual review of chemotherapy billing data, was utilized to assemble a high-risk neuroblastoma cohort (n = 952) from the Pediatric Health Information System (PHIS) Database and validated at a single institution [sensitivity 89.1%; positive predictive value (PPV) 96.1%]. This cohort provides a data source for future comparative effectiveness and clinical epidemiology studies in high-risk neuroblastoma patients.

